Geon-Ho Jahng1,2, Chang Hyun Yoo3, Seokha Jin4, DongKyu Lee4, and HyungJoon Cho4
1Radiology, Kyung Hee University Hospital at Gangdong, Seoul, Korea, Republic of, 2Medicine, Kyung Hee University, Seoul, Korea, Republic of, 3Physics, Kyung Hee University, Seoul, Korea, Republic of, 4Biomedical Engineering, Ulsan National Institute of Science and Technology, Ulsan, Korea, Republic of
Synopsis
We simulated the changes in microvascular (MV) MRI signals with and without existing amyloid-beta plaques or microbleeds in an
imaging voxel. The Monte Carlo simulations
with the finite perturber method were used to calculate MV
indices of mean vessel diameter (mVD), vessel size index (VSI), mean vessel density
(Q), blood volume fraction (BVf), and microvessel-weighted imaging (MvWI). The
simulation was performed with three different voxel environmental
conditions: only the MV structures, MV structures with amyloid-beta plaques, and
MV structures with microbleeds.
Introduction
Alzheimer’s
disease (AD) is the most common age-related neurodegenerative disorder, and
leads to cognitive decline and memory loss. AD is
a complex and progressive disease that is caused by an abnormal accumulation of
amyloid-beta (Aβ)42 plaque and tau proteins. Furthermore, cerebral microbleeds,
which are hemosiderin deposits in the brain, occur more frequently in patients
with AD than in the general population. Both microbleeds and Aβ42, which
comprise metallic materials, have a higher susceptibility than the surrounding
tissue in developing local field inhomogeneities. Therefore, both microbleeds
and Aβ42 should be considered while evaluating microvascular (MV) structure
changes in the AD brain.Purpose
There is currently no study in the literature that
has evaluated MV alterations with accumulation of amyloid-beta plaque proteins
or the presence of microbleeds in the AD brain. Therefore, in this study, we
simulated MRI signal changes by assuming three different environmental
conditions in the imaging voxel: only the normal MV structures, normal MV
structures in the presence of amyloid-beta plaques, and normal MV structures in
the presence of microbleeds. Alterations in MV imaging indices such as mean vessel diameter, vessel size index, mean vessel
density, blood volume fraction, and microvessel-weighted imaging were
calculated by using the differences in relaxation rates, ΔR2* and ΔR2, through
Monte Carlo simulations with application of FPM for the three conditions.Theory
1. Modeling of
vascular structures with and without amyloid-beta plaques or microbleeds
a) Modeling of vascular structures:
With
a 3-dimensional (3D) binary voxel of 256 x 256 x 256 mm3
(cell size = 1 mm3),
we assumed that vascular structures were randomly distributed in the voxel with
the blood volume fraction of the vessels equal to 2% and that the vessels were
finite cylinders. The radius of each cylinder ranged from 1 to 30
while holding the fractional volume constant
at 2%. Figure 1 shows a 3D image of the modeled vascular structures (1a) and
the corresponding cross-section taken along the z-axis (1b) of Figure 1a.
b) Modeling of vascular structures with amyloid-beta
plaques or microbleeds:
Within the 3D binary
voxel of the vascular structures, we modeled the amyloid-beta plaques and
microbleeds as spheres. The average Aβ loads have been reported as 3.81% (±
2.47) for AD patients and 1.83% (±1.84) for non-demented subjects (1,2). The
radius was set at between 1~20
to model the amyloid-beta plaque within the
voxel (3) and between 1~100
to model the microbleed within the voxel (4).
Figure 1c shows a 3D image of the modeled vascular structures with the
amyloid-beta plaque or microbleed structures, and Figure 1d shows the
corresponding cross-section taken along the z-axis of Figure 1c.
2. Calculation of
MRI signals and relaxation rates
The finite
perturbation method (FPM) method was used to calculate the change in a magnetic
field due to susceptibility differences between the vessels and the spherical
structures (5). The magnetic field differences between intra- and
extra-vascular spaces
and between the inner and outer spheres
were calculated using the following equation at
three different main magnetic field strengths (
), which were 1.5 T, 3 T, and 7 T.
3. Calculation of the microvascular indices
The
following MV indices were calculated using the simulation results of the
differences in the transverse relaxation rates, ΔR2* and ΔR2: mean vessel diameter (mVD) (6), vessel size index
(VSI) (7), mean vessel density (Q), blood volume fraction (BVf), and
microvessel-weighted imaging (MvWI) (8).Methods
The simulations were repeated with three different
main magnetic field strengths (1.5 T, 3 T, and 7 T) and two different contrast
agents, Gadolinium (Gd)–chelated and Superparamagnetic Iron Oxide Nanoparticles
(SPION) in three different voxel
environmental conditions of only the MV structures, MV structures with
amyloid-beta plaques, and MV structures with microbleeds. This
simulation was performed using a Matlab script on a personal computer, which
had an AMD Ryzen 1700 processor with 32GB memory. Table 1 summarizes the parameters used in the simulation.Results
Figure
2 shows the simulation results for the variations in MV indices against
amyloid plaque loads for microvessel size set at 5 μm at gradient-echo time of 40 ms
and spin-echo time of 80
ms. mVD decreased with increasing plaque loads. mVD was similar at 3 T and 7 T,
and with either Gd or SPION. In the amyloid-plaque model, mVD
and VSI decreased with increasing plaque loads, but BVf,
Q, and MvWI increased with increasing plaque loads. In the microbleed model, the MV indices of mVD and VSI increased with increasing vessel size. The MV indices of mVD, BVF, VSI and MvWI
increased with increasing microbleed loads, but
Q did not.Conclusion
In
conclusion, all MV indices were sensitive enough
to map accumulations of amyloid plaques, but did not vary
with increasing vessel size. The MV
indices,
except Q, were sensitive
to changes in
microbleed loads and microvessel
size. Therefore, we recommend evaluating MV structure changes in the AD human
brain using 3T MRI with a Gadolinium (Gd) contrast agent.Acknowledgements
This study was supported by the Basic
Science Research Program through the National Research Foundation (NRF) of
Korea funded by the Ministry of Education (2016R1D1A1B03930720, GHJ) and the National Research
Foundation of Korea (NRF) grant funded by Ministry of Science and ICT (No.
2020R1A2C1004749, GHJ), Republic of Korea.References
1)
Bennett, D. A., et al. Archives of
neurology 61, 378-384 (2004).
2)
Martikainen, P. et al. Neuropathology and applied neurobiology 36, 41-54 (2010).
3)
Galea, E. et al. PNAS 112, 15556-15561 (2015).
4)
Reuter, B. et al. Frontiers in aging neuroscience 8, 170 (2016).
5)
Pathak, A. P., et al. NeuroImage 40, 1130-1143 (2008).
6)
Dennie, J. et al. Magnetic resonance in medicine 40, 793-799 (1998).
7)
Tropres, I. et al. Magnetic resonance in medicine 45, 397-408 (2001).
8)
Jung, H. S. et al. NMR in biomedicine 29, 690-701 (2016).